PURPOSE: To determine the role of vascular endothelial growth factor (VEGF) in embryonic eye development and lens differentiation. METHODS: Expression of components of the VEGF signaling pathway during lens development and in adults was characterized by beta-galactosidase staining of VEGF-LacZ mice, immunohistochemistry, and real-time (q) PCR. Embryonic eyes from wild-type mice and VEGF120/120 mice were analyzed by light microscopy and immunohistochemistry. VEGF function during lens development was analyzed using eye explants treated with VEGF-neutralizing antibody. Direct function of VEGF was demonstrated on the human lens epithelial cell line, HLE-B3. RESULTS: Embryonic lens epithelium and posterior lens fibers expressed VEGF and VEGFR2. qPCR revealed VEGF164 as the major isoform in embryonic lens. Transgenic mice expressing only VEGF120 (VEGF120/120 mice) showed major defects in eye development, including microphthalmia, failed lens differentiation, and hyperplastic hyaloid vessels. The lens displayed abnormal cell patterning and differentiation associated with altered c-Maf, Prox1, and p57 expression pattern in the anterior epithelium. The number of proliferating epithelial cells was drastically reduced in VEGF120/120 lenses. Altered MIP26 cellular localization and reduced E-cadherin expression in the lens epithelium were observed. VEGF-neutralization led to reduced fiber elongation of eye explants. Exogenous VEGF increased survival and proliferation of HLE-B3 cell in a dose-dependent manner. CONCLUSIONS: Abnormalities in ocular development in VEGF120/120 mice suggest a role for VEGF not only in the formation of ocular vascular beds but also in the differentiation of the lens itself.
PURPOSE: To determine the role of vascular endothelial growth factor (VEGF) in embryonic eye development and lens differentiation. METHODS: Expression of components of the VEGF signaling pathway during lens development and in adults was characterized by beta-galactosidase staining of VEGF-LacZ mice, immunohistochemistry, and real-time (q) PCR. Embryonic eyes from wild-type mice and VEGF120/120 mice were analyzed by light microscopy and immunohistochemistry. VEGF function during lens development was analyzed using eye explants treated with VEGF-neutralizing antibody. Direct function of VEGF was demonstrated on the human lens epithelial cell line, HLE-B3. RESULTS:Embryonic lens epithelium and posterior lens fibers expressed VEGF and VEGFR2. qPCR revealed VEGF164 as the major isoform in embryonic lens. Transgenic mice expressing only VEGF120 (VEGF120/120 mice) showed major defects in eye development, including microphthalmia, failed lens differentiation, and hyperplastic hyaloid vessels. The lens displayed abnormal cell patterning and differentiation associated with altered c-Maf, Prox1, and p57 expression pattern in the anterior epithelium. The number of proliferating epithelial cells was drastically reduced in VEGF120/120 lenses. Altered MIP26 cellular localization and reduced E-cadherin expression in the lens epithelium were observed. VEGF-neutralization led to reduced fiber elongation of eye explants. Exogenous VEGF increased survival and proliferation of HLE-B3 cell in a dose-dependent manner. CONCLUSIONS: Abnormalities in ocular development in VEGF120/120 mice suggest a role for VEGF not only in the formation of ocular vascular beds but also in the differentiation of the lens itself.
Authors: Rupalatha Maddala; Pei-Feng Deng; Joseph M Costello; Eric F Wawrousek; Jacob S Zigler; Vasantha P Rao Journal: Lab Invest Date: 2004-06 Impact factor: 5.662
Authors: Knatokie M Ford; Magali Saint-Geniez; Tony E Walshe; Patricia A D'Amore Journal: Invest Ophthalmol Vis Sci Date: 2012-11-07 Impact factor: 4.799
Authors: Bhavani P Madakashira; Daniel A Kobrinski; Andrew D Hancher; Elizabeth C Arneman; Brad D Wagner; Fen Wang; Hailey Shin; Frank J Lovicu; Lixing W Reneker; Michael L Robinson Journal: Development Date: 2012-11-07 Impact factor: 6.868
Authors: M Yanagita; Y Kojima; M Kubota; K Mori; M Yamashita; S Yamada; M Kitamura; S Murakami Journal: J Dent Res Date: 2013-11-01 Impact factor: 6.116